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Abstract. This paper summarises the information given
on the 1986 EDTA Registry centre questionnaire which
was returned by 82% of the 2,065 known dialysis and
transplant centres in 33 European countries. Information
is given on the number of patients alive on haemodialysis
according to the type of dialysis facilities available where
the patient was receiving dialysis and the number of
patients receiving special types of dialysis. The centre
questionnaire also included questions on testing for HIV
infection, serological evidence or symptoms of AIDS
and the diagnosis of hepatitis B in patients and staff. The
data given in response to these questions are presented
together with data on the involvement of dietitians and
social workers in the treatment of patients with end stage
renal failure. Finally, information on transplant activity
in Europe and the treatment policies of transplanting
centres is provided.
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Introduction
The Registry of the European Dialysis and Transplant
Association - European Renal Association (EDTA
Registry) collects data from three sources: individual
patient, centre and mini questionnaires.
Each centre known to the EDTA Registry is requested
annually to complete a centre questionnaire and to pro-
vide core summary data on their unit's activity during the
year. By repeating each year core questions concerning
the number of patients accepted for renal replacement
therapy, total number of patients on treatment at the end
of the year, and number of patients undergoing special
forms of dialysis, the centre questionnaire provides a
unique opportunity to analyse trends in many aspects
of renal replacement therapy. Apart from these core
questions, additional data are requested in order to
investigate particular aspects. This is possible due to the
flexible format of the centre questionnaire. EDTA
Registry data on demography and special topics (for
example AIDS and hepatitis) are used not only by those
directly involved in medical care but also by national
and international health care authorities. The Registry,
therefore, feels obliged to present data annually. In this
communication, the results of the 1986 centre question-
naire are reported.
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Table 1. Summary of centres known to the EDTA Registry in 1986, the
number per million population (pmp) and the proportion (%) returning
the 1986 centre questionnaire. Population figures are taken from the
World Bank Atlas [1]
Table 2. Number of patients alive on haemodialysis on 31 December
1986 according to type of dialysis facilities available where the patient
was receiving dialysis. Type of dialysis facilities was defined on the centre
questionnaire as hospital (excluding limited/self-care), limited/self-care
Country
Algeria
Austria
Belgium
Bulgaria
Cyprus
Czechoslovakia
Denmark
Egypt
Fed. Rep. Germany
Finland
France
German Dem. Rep.
Greece
Hungary
Iceland
Ireland
Israel
Italy
Lebanon
Libya
Luxembourg
Morocco
Netherlands
Norway
Poland
Portugal
Spain
Sweden
Switzerland
Tunisia
Turkey
United Kingdom
Yugoslavia
Total Registry
Population
in
millions
21.865
7.545
9.853
8.980
0.660
15.497
5.101
47.108
61.065
4.919
55.133
16.716
9.937
10.660
0.241
3.560
4.296
56.945
2.624*
3.600
0.366
21.924
14.486
4.144
37.288
10.198
38.730
8.330
6.421
7.143
49.406
56.539
23.100
624.380
Known
centres
21
34
59
50
5
27
12
31
346
26
221
58
• 55
14
1
5
29
396
8
3
5
9
50
17
54
50
207
36
40
11
20
68
97
2065
Known
centres
PMP
1.0
4.5
6.0
5.6
7.6
1.7
2.4
0.7
5.7
5.3
4.0
3.5
5.5
1.3
4.1
1.4
6.8
7.0
3.0
0.8
13.7
0.4
3.5
4.1
1.4
4.9
5.3
4.3
6.2
1.5
0.4
1.2
4.2
3.3
Replied
(%)
61.9
97.1
91.5
94.0
100.0
100.0
100.0
67.7
78.6
100.0
87.3
98.3
61.8
100.0
100.0
100.0
100.0
65.7
0
66.7
100.0
66.7
92.0
100.0
96.3
90.0
85.0
97.2
97.5
90.9
90.0
92.6
74.2
81.8
ing unit, or other hospital) and patients' own homes
Country
Algeria
Austria
Belgium
Bulgaria
Cyprus
Czechoslovakia
Denmark
Egypt
Hospital
(excluding
self-care)
283
1410
2062
1052
140
1024
402
579
Fed. Rep. Germany 9234
Finland
France
German Dem. Ref
Greece
Hungary
Iceland
Ireland
Israel
Italy
Libya
Luxembourg
Morocco
Netherlands
Norway
Poland
Portugal
Spain
Sweden
Switzerland
Tunisia
Turkey
United Kingdom
Yugoslavia
Total Registry
263
9296
). 1723
1142
434
7
210
808
10 590
70
93
199
1302
133
1083
1660
6130
799
902
334
794
1752
2935
58 845
Self-care
in own
hospital
26
47
81
58
0
116
71
193
2099
0
224
104
109
7
0
0
45
326
17
0
32
427
7
3
159
176
5
99
0
0
230
605
5266
Self-care
in other
unit
0
3
120
0
0
21
26
28
4317
10
877
56
0
44
0
24
35
1727
0
0
0
168
15
8
192
1612
25
29
0
34
154
147
9672
Patients'
own
homes
23
46
87
0
0
3
51
0
1077
2
2010
0
0
28
0
15
41
757
0
7
2
139
33
0
0
234
31
144
0
24
1868
141
6763
Total
332
1506
2350
1110
140
1164
550
800
16 727
275
12407
1883
1251
513
7
249
929
13400
87
100
233
2036
188
1094
2011
8152
860
1174
334
852
4004
3828
80 546
*Most recent figure available
Materials and Methods
In early 1987, the centre questionnaire was sent to 2065
centres in 33 countries. After a reminder to return this
questionnaire, a response rate of 82% was achieved.
However, it should be borne in mind that those centres
returning this form did not always complete all the
appropriate questions. National keymen and national
registries contributed, supplemented and/or corrected
data. Data handling was carried out in the offices of the
EDTA Registry in London.
Demography, 1986
(a) Regular Dialysis and Transplantation
Table 1 summarises by country the number of centres
known to the EDTA Registry. It does not include satellite
units whose data are forwarded through the parent centre.
In 22 of the 33 countries reporting to the Registry, there
was a response rate of 90% or above.
(b) Special Forms of Haemodialysis
The Registry has obtained information concerning the
use of limited/self-care or satellite units in the treatment of
patients on haemodialysis for the first time in 1986.
Centres were asked to record separately the numbers of
patients alive on 31 December on hospital haemodialysis
(excluding limited/self-care), on haemodialysis with
limited/self-care in the unit's own hospital, or on haemo-
dialysis with limited/self-care in another unit (e.g., satel-
lite, free-standing unit or other hospital). The numbers
provided in response to this question are shown according
to country in Table 2. The same data shown as
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Fig. I. Proportion of patients on 31 December 1986 alive on hospital,
home, or limited/self-care haemodialysis in selected countries and for
the total Registry.
Centres were also asked to record the number of
haemodialysis patients alive at the end of 1986 on
bicarbonate haemodialysis, haemofiltration, haemo-
diafiltration, and haemodialysis combined with
haemoperfusion, and the number of patients who were
on continuous cycling peritoneal dialysis or on perito-
neal dialysis combined with haemodialysis. The
numbers given are shown by country in Table 3. As
can be seen in Fig. 2, the proportion of patients treated
by haemofiltration and haemodiafiltration at the end of
the years 1982-1986 changed little, whilst the percent-
age treated by bicarbonate haemodialysis continued to
rise rapidly.
proportions are depicted for selected countries in Fig. 1.
This demonstrates widely differing national policies.
However, it should be borne in mind that definitions for
self-care and limited care are not clearly set and may vary
between countries.
(c) AIDS and Hepatitis
In 1985 the Registry added a question to the centre
questionnaire regarding the testing of patients for HIV
antibodies. Centres were asked if 'no testing' was carried
out on their patients with end-stage renal failure, if tests
Table 3. Number of patients alive on special forms of haemodialysis/haemofiltration and peritoneal dialysis on 31
December 1986
Country
Algeria
Austria
Belgium
Bulgaria
Cyprus
Czechoslovakia
Denmark
Egypt
Fed. Rep. Germany
Finland
France
German Dem. Rep.
Greece
Hungary
Iceland
Ireland
Israel
Italy
Libya
Luxembourg
Morocco
Netherlands
Norway
Poland
Portugal
Spain
Sweden
Switzerland
Tunisia
Turkey
United Kingdom
Yugoslavia
Total Registry
Haemodialysis/haemofiltration
Bicarbonatt
HD
1
306
994
0
0
33
70
0
4290
137
3157
557
14
6
3
2
26
3632
0
30
11
426
15
36
13
904
65
205
0
2
281
158
15 374
; Haemo-
filtration
0
50
72
16
0
19
33
0
861
1
203
6
4
7
0
0
8
535
0
0
0
32
8
6
0
215
44
29
0
66
4
118
2337
Haemodia-
filtration
16
60
31
14
0
0
48
0
441
0
210
28
3
2
0
0
21
609
0
0
0
52
17
57
20
291
25
16
0
20
7
58
2046
HD+Haemo-
perfusion
0
36
0
10
18
24
0
0
285
0
50
83
2
15
0
0
37
47
0
0
0
0
0
0
49
46
11
20
60
54
0
88
935
Peritoneal dialysis
CCPD
0
1
7
0
0
0
15 •
5
29
5
93
0
0
0
0
4
0
52
0
0
0
11
1
3
3
14
11
3
0
0
67
13
337
PD + HD
4
0
0
0
0
1
1
43
4
1
5
3
1
7
0
0
7
5
0
0
4
8
0
5
3
I
0
0
0
28
6
41
178
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Fig. 2. Proportion of patients treated by haemofiltration, haemodiafilt-
ration, and bicarbonate haemodialysis at the end of the years 1982-1986.
Table 4. Summary of information concerning the practice of centres in
testing for HIV antibodies by country. The proportion of centres which
responded to the section on AIDS is also given
Country Testing for AIDS (% centres)
No
testing
In
selected
patients
In most
oral)
patients
centres
replied
Algeria 83 17 0 57.1
Austria 6 9 84 94.1
Belgium 30 6 65 91.4
Bulgaria 91 0 9 90.0
Cyprus 0 0 100 100.0
Czechoslovakia 92 0 8 96.3
Denmark 25 8 67 100.0
Egypt 65 24 12 54.8
Fed. Rep. Germany 17 27 56 76.9
Finland 46 15 38 100.0
France 13 15 72 86.1
German Dem. Rep. 77 9 14 96.6
Greece 7 10 83 52.7
Hungary 50 0 50 85.7
Iceland 100 0 0 100.0
Ireland 20 40 40 100.0
Israel 54 36 11 96.6
Italy 38 10 52 63.1
Libya 100 0 0 33.3
Luxembourg 0 60 40 100.0
Morocco 83 17 0 66.7
Netherlands 74 10 17 84.0
Norway 6 18 76 100.0
Poland 83 6 12 96.3
Portugal 9 7 84 86.0
Spain 41 21 38 78.7
Sweden 0 12 88 94.4
Switzerland 26 24 50 95.0
Tunisia 22 44 33 81.8
Turkey 69 19 13 80.0
United Kingdom 37 37 27 92.6
Yugoslavia 67 6 27 64.9
Total Registry 37 16 47 78.4
were done 'in selected patients' or 'in most, or all, of their
patients'. This question was asked again for 1986 and the
replies given are shown by country in Table 4. Although
selected
patients
al
patients
60
40
20
1985 1986
n=1356 n=1583
Fig. 3. Centre policy regarding testing for HIV antibodies in patients
with end-stage renal failure as reported on the 1985 and 1986 centre
questionnaire.
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Fig. 4. The percentage of centres in selected countries which reported no
testing for HIV antibodies in 1986.
the practice of testing varied widely between countries, the
proportion of centres which reported that no testing was
performed decreased between 1985 and 1986 from 57% to
37% (Fig. 3). Similarly, the proportion of centres who
reported HIV testing in most or all of their patients
increased from 30% to 47%. Over 60% of centres in
Europe were carrying out tests for HIV antibodies in at
least some of their patients. The data were examined for
those centres who reported no testing for HIV antibodies
in their unit. This information is shown for selected
countries in Fig. 4.
Centres reported that a total of 225 patients with end-
stage renal failure and on renal replacement therapy in
1986 had serological evidence of infection with HIV
(Table 5).
As in previous years, the Registry asked centres to
report the number of new cases in 1986 of hepatitis B both
in patients and staff. Although the number of cases
reported was approximately the same as those reported
for 1985 [2], the ratio of cases per thousand patients on
hospital haemodialysis was reduced from 21/1000 to 18/
1000 for patients and from 3.6/1000 to 3.2/1000 for staff
(Table 6). This decrease was not observed in all countries,
and in a few there was actually an increase.
EDTA Registry Centre Survey 1986
Table 5. Summary of information on patients with serological evidence
or symptoms of AIDS. The Table shows the number of patients with
serological evidence of infection with HIV in 1986, and of those, the
number whose positive serology was first detected in 1986. The number
of patients who developed symptoms of AIDS during the year is also
given
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Table 6. Hepatitis B diagnosed in patients and staff in 1986. The numbers
of cases are shown in absolute numbers and also expressed per thousand
patients on hospital haemodialysis at the end of the year
Country
Algeria
Austria
Belgium
Bulgaria
Cyprus
Czechoslovakia
Denmark
Egypt
Fed. Rep. Germany
Finland
France
German Dem. Rep.
Greece
Hungary
Iceland
Ireland
Israel
Italy
Libya
Luxembourg
Morocco
Netherlands
Norway
Poland
Portugal
Spain
Sweden
Switzerland
Tunisia
Turkey
United Kingdom
Yugoslavia
Total Registry
Cases of AIDS (n)
Serological
evidence
2
4
11
0
0
0
1
0
29
0
89
0
2
0
0
0
2
19
0
0
0
2
1
0
3
28
4
3
3
0
3
19
225
Positive
serology
1st detected
in 1986
0
2
3
0
0
0
1
0
15
0
51
0
2
0
0
0
2
18
0
0
0
1
0
0
1
21
4
1
3
0
3
11
139
Developed
symptoms
in 1986
0
0
0
0
0
0
0
0
5
0
10
0
1
0
0
0
1
6
0
0
0
0
0
0
0
0
0
0
0
0
2
0
25
(d) Dietitians and Social Workers
Centres were asked if 75% or more of their new
patients had been seen by a dietitian and/or social
worker during the year. Only the 1178 centres which
reported having accepted four or more new patients
with end-stage renal failure in 1986 were included in
the analysis. Of these centres, 1072 provided infor-
mation concerning dietitians and 1083 concerning
social workers. It can be seen from Table 7 that, over-
all, a greater proportion of centres involved dietitians
with new patients (51%) than social workers (36%),
though this was not the case in all countries reporting
to the Registry. This is illustrated for selected
countries, or groups of countries, in Fig. 5 concerning
Country
Algeria
Austria
Belgium
Bulgaria
Cyprus
Czechoslovakia
Denmark
Egypt
Fed. Rep. Germany
Finland
France
German Dem. Rep.
Greece
Hungary
Iceland
Ireland
Israel
Italy
Libya
Luxembourg
Morocco
Netherlands
Norway
Poland
Portugal
Spain
Sweden
Switzerland
Tunisia
Turkey
United Kingdom
Yugoslavia
Total Registry
Patients
HepB
n
36
26
27
18
1
154
0
32
51
0
83
225
15
28
0
0
4
100
0
1
8
3
0
137
85
62
1
9
30
56
6
140
1338
Cases/1000
pats on
Hosp. HD
116.5
17.8
11.9
16.2
7.1
132.6
0
40.0
3.3
0
8.0
119.5
12.0
57.7
0
0
4.5
7.9
0
10.8
34.6
1.6
0
125.2
42.3
7.8
1.2
8.7
89.8,
67.6
2.8
38.0
18.1
Staff
HepB
n
8
2
3
8
0
11
0
2
5
0
3
38
2
2
0
0
0
20
1
0
4
0
0
61
8
9
0
0
2
5
0
41
235
Cases/1000
pats on
Hosp. HD
25.9
1.4
1.3
7.2
0
9.5
0
2.5
0.3
0
0.3
20.2
1.6
4.1
0
0
0
1.6
11.5
0
17.3
0
0
55.8
4.0
1.1
0
0
6.0
6.0
0
11.1
3.2
dietitians and in Fig. 6 concerning social workers. The
proportion of centres which involved dietitians and
social workers is much more impressive in the United
Kingdom and Benelux and Nordic countries than in other
European countries.
(e) Transplantation Activity
By the end of 1986 approximately 65 000 transplants
had been performed in Europe, of which 9216 were
performed in 1986 (Table 8). The number of trans-
plants performed annually continued to rise and this
increase is illustrated in Fig. 7 which shows the number
of transplants performed per million population in
selected countries for each of the years 1976, 1981 and
1986. Figure 8 shows the proportion of transplants
performed in 1986 according to centre activity. Centre
activity has been defined by the number of transplants
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Table 7. Numbers of centres who reported that they had accepted four or more new patients
for the treatment of end-stage renal failure in 1986 and the number (and percentage) of these
centres which reported that 75% or more of their new patients were seen by a dietitian/social
worker in 1986. The number of centres which responded to this section on the centre question-
naire is also given
Country
Algeria
Austria
Belgium
Bulgaria
Cyprus
Czechoslovakia
Denmark
Egypt
Fed. Rep. Germany
Finland
France
German Dem. Rep.
Greece
Hungary
Iceland
Ireland
Israel
Italy
Libya
Luxembourg
Morocco
Netherlands
Norway
Poland
Portugal
Spain
Sweden
Switzerland
Tunisia
Turkey
United Kingdom
Yugoslavia
Total Registry
Eligible
f^n f rp< *
centres
n
12
25
42
25
3
24
9
15
194
13
141
44
21
10
1
4
20
183
2
3
6
35
14
43
23
110
21
25
5
8
57
40
1178
Dietitians
Centres
replying
n
8
23
40
23
3
23
8
11
179
12
131
40
16
8
I
4
20
162
1
2 .
6
30
14
39
22
99
21
23
4
8
56
35
1072
'Yes'
n
0
11
32
2
3
8
7
2
85
10
87
23
7
5
1
4
15
69
0
1
0
30
10
12
10
8
16
18
2
4
53
11
546
%
0
48
80
9
100
35
88
18
47
83
66
58
44
63
100
100
75
43
0
50
0
100
71
31
45
8
76
78
50
50
95
31
51
Social workers
Centres
replying
n
11
24
42
24
3
22
7
11
176
13
131
42
19
7
1
4
20
164
1
2
6
30
14
40
22
104
21
22
4
6
56
34
1083
Yes'
n
5
3
36
2
0
4
6
1
36
12
40
12
4
1
0
2
17
56
0
1
0
29
8
4
14
20
12
8
2
0
45
8
388
%
45
13
86
8
0
18
86
9
20
92
31
29
21
14
0
50
85
34
0
50
0
97
57
10
64
19
57
36
50
0
80
24
36
'Eligibility for inclusion in this table; four or more new patients in 1986 reported on the centre
questionnaire
Benelux
NorOc
GDR
Total Registry
FRG/Auatr.
Lath
3888888888
25 50
PB1 CBfT
75 10O
Fig. 5. Proportion of centres, in selected countries or groups of countries,
reporting that 75% or more of their new patients in 1986 were seen by a
dietitian. (UK = United Kingdom; Benelux = Belgium, Luxembourg,
Netherlands; Nordic = Denmark, Finland, Iceland, Norway, Sweden;
GDR = German Democratic Republic; FRG/Austr. = Federal Republic
of Germany/Austria; Latin = France, Italy, Portugal, Spain).
performed in 1986. More than 40% of all grafts were
performed in the 49 centres which carried out 51-100
grafts during 1986.
(f) Waiting List for Transplantation
Of all the patients on dialysis at the end of 1986,26% were
on a waiting list for cadaver transplant (Table 8), with
marked variation between countries. A 'projected waiting
time' was calculated by dividing the number of patients
on the waiting list at the end of 1986 by the number of
transplants performed during 1986. Figure 9 shows the
'projected waiting time' in selected countries, which range
from approximately 6 months in Norway to nearly 8 years
in Portugal. Generally the shortest 'projected waiting
EDTA Registry Centre Survey 1986
Benelux
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Fig. 6. Proportion of centres, in selected countries or groups of countries,
reporting that 75% or more of their new patients in 1986 were seen by a
social worker. (Countries and regions as denned in Fig. S.)
Table 8. Transplant activity in 1986. Total number of grafts and
number per million population, the proportion of dialysis patients on
a waiting list for cadaver transplant at end of 1986 as reported by di-
alysis centres, and the proportion of highly sensitised patients on the
waiting list
Transplants
p.m.p.
20 -
1 0 - GDR
1976 1981
Year
1986
Fig. 7. Number of transplants performed per million population
(p.m.p.) in selected countries for each of the years 1976,1981 and 1986.
(DK = Denmark; S = Sweden; CH= Switzerland; SF = Finland;
UK = United Kingdom; B = Belgium; FRG = Federal Republic of
Germany; F = France; E = Spain; GDR = German Democratic
Republic; and 1 = Italy.)
Country Grafts in 1986
p.m.p.
Patients on
waiting list
% highly
sensitised*
Algeria 2 0.1 23.3 35.1
Austria 271 35.9 35.7 12.9
Belgium 296 30.1 14.4 14.2
Bulgaria 2 0.2 34.5 6.9
Cyprus 0 0.0 30.7 —
Czechoslovakia 151 9.8 41.4 13.5
Denmark 227 44.5 23.1 10.2
Egypt 80 1.7 0.6 —
Fed. Rep. Germany 1627 26.7 19.9 6.4
Finland 143 29.1 32.4 9.0
France 1319 23.9 16.4 16.0
German Dem. Rep. 167 10.0 27.5 7.5
Greece 62 6.2 17.8 11.3
Hungary 52 4.9 58.0 9.1
Iceland 0 0.0 78.9 —
Ireland 100 28.1 54.8 19.8
Israel 90 21.0 22.4 20.2
Italy 250 4.4 18.6 8.8
Lebanon 0 0.0 0.0 —
Libya 0 0.0 0.0 —
Luxembourg 5 13.7 21.8 7.1
Morocco 1 0.1 9.3 0.0
Netherlands 430 29.7 25.6 18.4
Norway 171 41.3 38.5 25.9
Poland 279 7.5 51.4 6.0
Portugal 92 9.0 28.2 8.5
Spain 877 22.7 39.9 10.6
Sweden 347 41.7 28.9 13.3
Switzerland 259 40.3 20.5 15.4
Tunisia 9 1.3 20.6 —
Turkey 145 2.9 46.1 1.2
United Kingdom 1625 28.8 44.9 11.2
Yugoslavia 137 5.9 29.0 9.4
Total Registry 9216 14.8 25.6 10.6
•Most recent serum reacting with more than 80% of random donor
panel
Per cent
transplants
Ctntnt n 78
50-1
40-
30-
20-
10-
1-10 11-25 26-50 51-100 >100
Centre activity (transplants/year)
Fig. 8. Percent transplants performed in 1986 according to centre
activity, which is defined by number of transplants performed in 1986.
Years 4 -
2 -
N SF UK F GDR B CS
Country
Fig. 9. 'Projected waiting time' (in years) in December 1986 for a renal
transplant in selected countries. (N = Norway; SF=Finland; UK =
United Kingdom; F= France; GDR = German Democratic Republic;
B = Belgium; CS = Czechoslovakia; E=Spain; and P=Portugal.)
times' were calculated for the Nordic countries and
Switzerland, countries which have previously demon-
strated high transplant activity.
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Table 9. Most commonly reported upper age limit for
a donor from which centres would accept a cadaver
kidney. Results are shown for selected countries
40 - ,
Country Upper age limit
(years)
Nordic None
France . 60
Fed. Rep. Germany 60-70
Greece 70
Israel 70
Italy 60
Netherlands 70
Portugal 60
Spain 60
Switzerland 60
United Kingdom 70
1-10 11-25 26-50 51-100 >100
Centre activity (transplants/year)
no limit ]<70yf• «60yr« <S0yrs
Fig. 10. Centre policy concerning the upper age limit for a donor from
which a cadaver kidney would be accepted, according to centre activity.
(g) Cadaveric Kidney Graft Retrieval
The transplant centres were asked for their policy
concerning the upper age limit for a donor from which
they would accept a cadaver kidney. Table 9 shows the
most commonly reported acceptable upper age limit for a
donor in selected countries. The centre policy concerning
the upper age limit for a donor according to centre activity
is shown in Fig. 10 and demonstrates that centres with
high transplant activity are more willing to accept
donors with a higher age than centres with a low
transplant activity. One wonders whether activity is low
in some centres because of a reluctance to use donors from
the upper age range.
It was also found that the greater the centre activity, the
higher the proportion of centres which in 1986 sent a
surgical team to other hospital(s) to perform cadaver
donor nephrectomy (Fig. 11). The proportion of centres
(excluding paediatric units) which sent a surgical team to
other hospital(s) for cadaver donor nephrectomy in 1986
according to country or region is shown in Fig. 12. In
Nordic countries this practice has been adopted by nearly
all the transplant units (90%), whereas in Spain only a
small proportion of transplant units (17%) sent a surgical
3 0 -
Per cent
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2 0 -
1 0 -
1-10 11-25 26-50 51-100 >100
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Fig. 11. Proportion of centres sending a surgical team to other hospital(s)
for cadaver donor nephrectomy in 1986, according to centre activity and
in paediatric centres.
Per cent centres
80 100
Fig. 12. Proportion of centres sending a surgical team to other hospital(s)
for cadaver donor nephrectomy in 1986 according to country or region.
Paediatric centres have been excluded from this analysis. (Benelux =
Belgium, Netherlands, Luxembourg; FRG = Federal Republic of
Germany; Nordic = Denmark, Finland, Iceland, Norway, Sweden;
'Alps'= Austria, Switzerland; Eastern = Czechoslovakia, German
Democratic Republic, Hungary, Poland.)
team to other hospital(s) for procurement of cadaver
kidneys.
(h) Immunosuppressive Regimes
Transplant centres were asked to record their policy in
1986 regarding the use of antilymphocyte globulin
(ALG), antithymocyte globulin (ATG) or monoclonal
antibodies for prophylactic immunosuppression, and the
use of ALG, ATG, monoclonal antibodies and plasma
exchange for antirejection therapy. Results concerning
prophylactic immunosuppression are shown in Table 10
according to country. Twelve per cent of centres reported
having used either ALG, ATG or monoclonal antibodies
for prophylactic immunosuppression for most or all of
their patients, 20% reported one of these immuno-
suppressive agents for some of their patients, and 62%
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Table 10. Centre policy concerning the use of ALG, ATG or monoclonal antibodies for prophylactic immunosuppression in 1986. Numbers of
centres reporting that these regimes were never used, used in some patients, or used in most or all patients
Country
Austria
Belgium
Czechoslovakia
Denmark
Egypt
Fed. Rep. Germany
Finland
France
German Dem. Rep.
Greece
Hungary
Ireland
Israel
Italy
Netherlands
Norway
Poland
Portugal
Spain
Sweden
Switzerland
Turkey
United Kingdom
Yugoslavia
Total Registry
ALG
Never
used
4
2
4
4
2
12
0
2
2
0
2
1
1
6
7
1
3
2
15
3
5
2
29
1
110
Some
patients
1
2
0
0
0
5
1
3
0
1
0
0
0
0
0
0
0
0
5
0
0
0
3
2
23
Most/all
patients
0
1
0
0
0
2
0
12
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
2
18
ATG
Never
used
4
5
4
4
2
11
0
8
1
0
2
1
I
6
6
1
3
2
14
2
3
2
27
3
112
Some
patients
2
0
0
0
0
8
1
5
1
0
0
0
0
0
0
0
0
0
4
2
2
0
7
1
33
Most/all
patients
0
0
0
0
0
0
0
2
0
0
0
0
0
0
1
0
0
0
2
0
1
0
0
0
6
Monoclonal antibodies
Never
used
4
5
4
4
2
17
1
12
2
0
2
0
1
5
6
1
3
2
19
2
5
2
31
5
135
Some
patients
1
0
0
0
0
3
0
3
0
0
0
0
0
1
1
0
0
0
1
0
1
0
2
0
13
Most/all
patients
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100- ,
eo-
Per cent
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Fig. 13. Proportion of centres using ALG, ATG, monoclonal antibodies
or plasma exchange for prophylactic immunosuppression or in the treat-
ment of rejection episodes in 1986, according to centre activity and in
paediatric centres.
never to have used any of these agents. Table 12 gives
information by country concerning treatment of rejection
episodes.
Figure 13 shows that the higher the transplant activity,
the greater the percentage of centres which used ALG,
ATG, monoclonal antibodies or plasma exchange for
either prophylactic immunosuppression or treatment of
rejection episodes. Most centres performing more than 10
transplants in 1986 used one or several of these agents for
the treatment of at least some rejection episodes.
Table 11. Number of combined kidney/pancreas transplants performed
in 1986 according to country and number of centres performing these
transplants
Country Transplants Centres
Austria
Belgium
Czechoslovakia
Fed. Rep. Germany
France
German Dem. Rep.
Italy
Netherlands
Norway
Spain
Sweden
Switzerland
United Kingdom
Total Registry
5
3
4
25
13
2
3
10
10
4
31
4
8
122
1
2
1
5
2
1
2
3
1
2
4
1
4
29
A total of 21% of transplant centres were using mono-
clonal antibodies. Again, there is a relationship between
the use of monoclonal antibodies and centre activity. Of
centres performing 50-100 transplants in 1986, more than
40% reported at least occasional use of monoclonal anti-
bodies. Approximately 22% of transplant centres
Table 12. Centre policy concerning the use or ALG, ATG, monoclonal antibodies or plasma exchange for antirejection therapy in 1986. Number or centres reporting that these
regimes were never used, used in some rejection episodes, or used in most or all rejection episodes
Country
Austria
Belgium
Czechoslovakia
Denmark
Egypt
Fed. Rep. Germany
Finland
France
German Dem. Rep.
Greece
Hungary
Ireland
Israel
Italy
Netherlands
Norway
Poland
Portugal
Spain
Sweden
Switzerland
Turkey
United Kingdom
Yugoslavia
Total Registry
ALG
Never
used
4
3
2
4
2
10
0
0
2
0
1
1
2
5
7
1
2
2
8
3
3
1
19
0
82
Some
episodes
0
2
I
0
0
9
1
II
0
1
1
0
0
1
0
0
1
0
12
0
2
1
14
4
61
Most/all
episodes
0
1
1
0
0
0
0
6
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
1
10
ATG
Never
used
0
2
2
4
I
4
0
10
0
0
2
1
1
5
0
1
2
3
7
0
0
2
17
3
67
Some
episodes
5
3
2
0
1
13
1
5
1
0
0
0
1
1
5
0
1
0
12
4
6
0
17
1
79
Most/all
episodes
1
0
0
0
0
2
0
1
1
0
0
0
0
0
2
0
0
0
1
0
0
0
0
1
9
Monoclonal antibodies
Never
used
2
3
4
3
1
9
1
10
2
0
2
0
I
3
6
1
2
2
19
2
5
1
25
4
108
Some
episodes
3
2
0
1
1
10
0
6
0
0
0
1
1
3
I
0
1
0
1
1
1
1
7
I
42
Most/all
episodes
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
Plasma exchange
Never
used
1
4
3
4
2
11
1
8
1
0
2
0
1
6
7
1
3
1
16
2
4
1
25
0
104
Some
episodes
3
1
1
0
0
9
0
5
1
1
0
1
1
0
0
0
0
1
4
1
1
1
8
5
44
Most/all
episodes
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50eport
 i
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reported occasional use of plasma exchange for the treat-
ment of rejection episodes and this percentage did not
appear to depend on centre activity.
(i) Combined Kidney and Pancreas Grafts
In 1986,28 centres performed 122 combined kidney/pan-
creas transplants (Table 11). This number should be com-
pared to the 58 grafts reported by 14 centres in 1983 [3].
The numbers for each country are small, with the highest
number in 1986 reported from Sweden. All four Swedish
transplant centres carried out combined kidney/pancreas
transplants and between them reported a total of 31 such
grafts.
Conclusions
EDTA Registry centre questionnaire data continues to
be an important source for analysing trends in renal
replacement therapy. The large number of centres
reporting outweighs individual shortcomings in these
types of analyses. This paper summarises several topics
and, wherever possible, data have been presented on a
countrywide basis.
Although there are national variations in treatment,
attitudes and modalities, some generalised conclusions
can be made. The total number of patients on hospital
haemodialysis has started to level off, accompanied by a
decrease in the number of patients treated with home
haemodialysis. On the other hand, the number of patients
alive on CAPD or with a functioning graft continues to
increase.
The frequency of new cases of hepatitis B amongst
patients and staff declined in 1986. Renal transplant ac-
tivity is still rapidly increasing, but the number of patients
on a waiting list for a renal graft was much higher than the
number of available organs in most countries. Also the
number of combined kidney/pancreas transplant oper-
ations increased, but only a minority of patients with dia-
betic end-stage renal failure were treated by this procedure.
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